Abstract
To fight human vector-borne diseases, first releases of sterile transgenic mosquitoes have been performed. Someday, disease-refractory mosquitoes will replace wild types to stop transmission. For such population replacements, gene drive mechanisms must be established that allow local confinement and reversibility.
